Cargando…
Genome Guided Personalized Drug Therapy in Attention Deficit Hyperactivity Disorder
ADHD is a common behavioral syndrome with a heritability of 70–80%. Genome wide sequencing and association studies indicate that ADHD risk variants are distributed across a wide range of allele frequencies and relative risks. Several common single nucleotide variants (SNPs) have been identified that...
Autor principal: | Haavik, Jan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9271625/ https://www.ncbi.nlm.nih.gov/pubmed/35832601 http://dx.doi.org/10.3389/fpsyt.2022.925442 |
Ejemplares similares
-
Adults with Attention-Deficit/Hyperactivity Disorder – A Brain Magnetic Resonance Spectroscopy Study
por: Dramsdahl, Margaretha, et al.
Publicado: (2011) -
Alcohol and drug use disorders in adult attention-deficit/hyperactivity disorder: Prevalence and associations with attention-deficit/hyperactivity disorder symptom severity and emotional dysregulation
por: Anker, Espen, et al.
Publicado: (2020) -
Viloxazine in the Treatment of Attention Deficit Hyperactivity Disorder
por: Edinoff, Amber N., et al.
Publicado: (2021) -
Attention Deficit Hyperactivity Disorder: Association With Obesity and Eating Disorders
por: Ravi, Prithvi, et al.
Publicado: (2020) -
Why the Diagnosis of Attention Deficit Hyperactivity Disorder Matters
por: Hamed, Alaa M., et al.
Publicado: (2015)